Impact of Regular Physical Activity on the NAD(P)H Oxidase and Angiotensin Receptor System in Patients With Coronary Artery Disease
- 8 February 2005
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 111 (5) , 555-562
- https://doi.org/10.1161/01.cir.0000154560.88933.7e
Abstract
Background— In patients with stable coronary artery disease, physical exercise training (ET) improves endothelial dysfunction. A potential mechanism mediating the enhanced vasomotor function is a reduced breakdown of endothelium-derived nitric oxide by reactive oxygen species (ROS). The aim of the present study was to analyze the impact of ET on sources of ROS generation in the left internal mammary artery of patients with symptomatic coronary artery disease. Methods and Results— In left internal mammary artery rings sampled during bypass surgery from 45 patients randomized to either a training (n=22) or an inactive control (n=23) group, the mRNA expression of NAD(P)H oxidase subunits, NAD(P)H oxidase activity, and ROS production were assessed. In addition, endothelial function, expression of angiotensin II (Ang II) receptor type 1 and 2 (AT 1 -R and AT 2 -R), and Ang II-mediated vasoconstriction were determined. ET resulted in a significant lower expression of gp91 phox (23.1±0.5 versus 69.1±18.1 arbitrary units, training versus control), p22 phox (0.7±0.3 versus 2.0±0.5 arbitrary units), and Nox4 (2.7±1.2 versus 5.4±1.0 arbitrary units). Enzymatic activity (2.1±0.3 versus 4.9±0.4 mU/mg) and ROS generation (0.02±0.01 versus 0.06±0.02 arbitrary units) were significantly lower in the training compared with the control group. On a functional level, ET resulted in improved acetylcholine-mediated vasodilatation and a 49% reduction in Ang II–induced vasoconstriction, accompanied by lower AT 1 -R (3.7±0.8 versus 16.6±5.7 arbitrary units, training versus control) and higher AT 2 -R (7.8±2.5 versus 1.6±0.7 arbitrary units) mRNA expression. Conclusions— ET reduces vascular expression of NAD(P)H oxidase and AT 1 -R, resulting in decreased local ROS generation. These molecular effects converge in a reduced Ang II–mediated vasoconstriction.Keywords
This publication has 24 references indexed in Scilit:
- gp91phox-Containing NADPH Oxidase Mediates Endothelial Dysfunction in Renovascular HypertensionCirculation, 2004
- Nox4 as the Major Catalytic Component of an Endothelial NAD(P)H OxidaseCirculation, 2004
- Pulsatile Versus Oscillatory Shear Stress Regulates NADPH Oxidase Subunit ExpressionCirculation Research, 2003
- c-Src Induces Phosphorylation and Translocation of p47phoxArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Role of oxidative stress in atherosclerosisThe American Journal of Cardiology, 2003
- NAD(P)H Oxidase-Derived Reactive Oxygen Species as Mediators of Angiotensin II SignalingAntioxidants and Redox Signaling, 2002
- Angiotensin II Stimulation of NAD(P)H Oxidase ActivityCirculation Research, 2002
- Superoxide Production and Expression of Nox Family Proteins in Human AtherosclerosisCirculation, 2002
- Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor gene in miceNature, 1995
- Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptorNature, 1995